These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20056250)

  • 1. Pittsburgh compound B binding in poststroke dementia.
    Mok V; Leung EY; Chu W; Chen S; Wong A; Xiong Y; Lam W; Ho CL; Wong KS
    J Neurol Sci; 2010 Mar; 290(1-2):135-7. PubMed ID: 20056250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
    Scheinin NM; Aalto S; Koikkalainen J; Lötjönen J; Karrasch M; Kemppainen N; Viitanen M; Någren K; Helin S; Scheinin M; Rinne JO
    Neurology; 2009 Oct; 73(15):1186-92. PubMed ID: 19726751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment.
    Tolboom N; van der Flier WM; Yaqub M; Koene T; Boellaard R; Windhorst AD; Scheltens P; Lammertsma AA; van Berckel BN
    Neurology; 2009 Dec; 73(24):2079-85. PubMed ID: 20018636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits of pure subcortical vascular dementia vs. Alzheimer disease: PiB-PET-based study.
    Yoon CW; Shin JS; Kim HJ; Cho H; Noh Y; Kim GH; Chin JH; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Seo SW; Na DL
    Neurology; 2013 Feb; 80(6):569-73. PubMed ID: 23325910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging.
    Hatashita S; Yamasaki H
    J Alzheimers Dis; 2010; 21(3):995-1003. PubMed ID: 20693641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of brain amyloid in dementia: a review.
    Quigley H; Colloby SJ; O'Brien JT
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images.
    Hosokawa C; Ishii K; Kimura Y; Hyodo T; Hosono M; Sakaguchi K; Usami K; Shimamoto K; Yamazoe Y; Murakami T
    J Nucl Med; 2015 Dec; 56(12):1910-5. PubMed ID: 26359262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
    Price JC; Klunk WE; Lopresti BJ; Lu X; Hoge JA; Ziolko SK; Holt DP; Meltzer CC; DeKosky ST; Mathis CA
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1528-47. PubMed ID: 15944649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of Pittsburgh compound-B-negative dementia.
    Takeuchi J; Shimada H; Ataka S; Kawabe J; Mori H; Mizuno K; Wada Y; Shiomi S; Watanabe Y; Miki T
    Dement Geriatr Cogn Disord; 2012; 34(2):112-20. PubMed ID: 22947919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study.
    Degerman Gunnarsson M; Lindau M; Wall A; Blennow K; Darreh-Shori T; Basu S; Nordberg A; Larsson A; Lannfelt L; Basun H; Kilander L
    Dement Geriatr Cogn Disord; 2010; 29(3):204-12. PubMed ID: 20332638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease.
    Hamelin L; Lagarde J; Dorothée G; Potier MC; Corlier F; Kuhnast B; Caillé F; Dubois B; Fillon L; Chupin M; Bottlaender M; Sarazin M
    Brain; 2018 Jun; 141(6):1855-1870. PubMed ID: 29608645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Pittsburgh Compound-B Accumulation in the Subcortical White Matter of Alzheimer's Disease Brain.
    Wakabayashi Y; Ishii K; Hosokawa C; Hyodo T; Kaida H; Yamada M; Yagyu Y; Tsurusaki M; Kozuka T; Sugimura K; Murakami T
    Kobe J Med Sci; 2017 Mar; 62(5):E136-E141. PubMed ID: 28289271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal volume and shape in pure subcortical vascular dementia.
    Kim GH; Lee JH; Seo SW; Kim JH; Seong JK; Ye BS; Cho H; Noh Y; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Kim ST; Hwang JW; Jeong JH; Na DL
    Neurobiol Aging; 2015 Jan; 36(1):485-91. PubMed ID: 25444608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
    Morris JC; Roe CM; Grant EA; Head D; Storandt M; Goate AM; Fagan AM; Holtzman DM; Mintun MA
    Arch Neurol; 2009 Dec; 66(12):1469-75. PubMed ID: 20008650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
    Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study.
    Bahar-Fuchs A; Chételat G; Villemagne VL; Moss S; Pike K; Masters CL; Rowe C; Savage G
    J Alzheimers Dis; 2010; 22(4):1081-7. PubMed ID: 20930316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Cognitive Improvement After Benfotiamine Administration in Patients with Alzheimer's Disease.
    Pan X; Chen Z; Fei G; Pan S; Bao W; Ren S; Guan Y; Zhong C
    Neurosci Bull; 2016 Dec; 32(6):591-596. PubMed ID: 27696179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Amyloid-β on Cognitive Decline After Stroke/Transient Ischemic Attack: Three-Year Longitudinal Study.
    Liu W; Wong A; Au L; Yang J; Wang Z; Leung EY; Chen S; Ho CL; Mok VC
    Stroke; 2015 Nov; 46(11):3074-80. PubMed ID: 26382174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.